Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 2, 2005, Pages 209-214

  Tan, K C B ^a   Tso, A W K ^a   Ma, O C K ^b   Pang, R W C ^b   Lam, K S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Apolipoprotein E polymorphism; Insulin resistance; Postprandial lipemia; Remnant like lipoproteins; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; INSULIN; LIPOPROTEIN; REMNANT LIKE LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 16344364320     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.504     Document Type: Article

References (32)

1. Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998; 81: 13B-17B.
2. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Int Med 1999; 246: 341-355.
3. Jeppesen J, Hollenbeck CB, Zhou MY, et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995; 15: 320-324.
4. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129: 79-88.
5. Vansant G, Mertens A, Muls E. Effect of exercise training on long-term weight maintenance in weight-reduced men. Metabolism 1999; 48: 15-21.
6. Fernandez-Miranda C, Cancelas P, Sanz M, Porres A, Gamez Gerique J. Influence of apolipoprotein-E phenotypes on postprandial lipoprotein metabolism after three different fat loads. Nutrition 2001; 17: 529-533.
7. Sharrett AR, Heiss G, Chambless LE, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 275-281.
8. Nero N, Syvanne M, Taskinen MR. Postprandial lipid metabolism in diabetes. Atherosclerosis 1998; 141: S53-S55.
9. Mero N, Malmstrom R, Steiner G, Taskinen MR, Syvanne M. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150: 167-177.
10. Reznik Y, Morello R, Pousse P, Mahoudeau J, Fradin S. The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism 2002; 51: 1088-1092.
11. Ai M, Tanaka A, Ogita K, et al. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. J Am Coll Cardiol 2001; 38: 1628-1632.
12. Meigs JB, Ordovas JM, Cupples LA, et al. Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care 2000; 23: 669-674.
13. Elossua R, Demissie S, Cupples LA, et al. Obesity modulates the association among apo E genotype, insulin, and glucose in men. Obes Res 2003; 11: 1502-1508.
14. Tan KC, Tso AW, Tam SC, Pang RW, Lam KS. Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with type 2 diabetes mellitus. Diabet Med 2002; 19: 944-948.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
16. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
17. Leary ET, Wang T, Baker DJ, et al. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem 1998; 44: 2490-2498.
18. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 1992; 33: 447-454.
19. Havel RJ. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol 2000; 11: 615-620.
20. Taniguchi A, Fukushima M, Sakai M, et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766-1769.
21. Funada J, Sekiya M, Otani T, Watanabe K, Sato M, Akutsu H. The close relationship between postprandial remnant metabolism and insulin resistance. Atherosclerosis 2004; 172: 151-154.
22. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-365.
23. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003; 46: 733-749.
24. Schneeman BO, Koyite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B48 and B100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993; 90: 2069-2073.
25. Tan CE, Tai ES, Tan CS, et al. APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 2003; 170: 253-260.
26. Saito M, Eto M, Kaku K. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes. Metabolism 2002; 51: 964-969.
27. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994; 54: 341-360.
28. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochim Biophys Acta 1996; 1303: 22-30.
29. Dart A, Sherrard B, Simpson H. Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis 1997; 130: 161-170.
30. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571-1577.
31. Brown AJ, Roberts DC. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 1991; 11: 1737-1744.
32. Bergeron N, Havel RJ. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest 1996; 97: 65-72.